PSYCH SYMPOSIUM
LONDON
Previous Speakers
-
![Christian Angermayer]()
Christian Angermayer
FOUNDER
APEIRON INVESTMENT GROUP -
![Rivki Stern]()
Rivki Stern
CEO
SHORTWAVE PHARMA -
![Professor Robin Carhart-Harris]()
Professor Robin Carhart-Harris
HEAD OF THE CENTRE FOR PSYCHEDELIC RESEARCH
IMPERIAL COLLEGE LONDON -
![Charlotte Nichols]()
Charlotte Nichols
MEMBER OF UK PARLIAMENT
LABOUR PARTY -
![MIKULÁŠ PEKSA]()
MIKULÁŠ PEKSA
MEP FOR CZECH REPUBLIC
EUROPEAN PARLIAMENT -
![Claudia Canavan]()
Claudia Canavan
HEALTH EDITOR
WOMEN'S HEALTH -
![AMIR INAMDAR]()
Dr. AMIR INAMDAR
CHIEF MEDICAL OFFICER
CYBIN INC -
![Professor Celia Morgan]()
Professor Celia Morgan
PROFESSOR OF PSYCHOPHARMACOLOGY
UNIVERSITY OF EXETER & AWAKN LIFE SCIENCES -
![Cyrus Engerer]()
Cyrus Engerer
MEP FOR MALTA
EUROPEAN PARLIAMENT -
![Clare Knight]()
Clare Knight
SENIOR CLINICAL TRIALS MANAGER
CLERKENWELL HEALTH -
![DAVID ERRITZOE]()
DAVID ERRITZOE
CLINICAL SENIOR LECTURER & CONSULTANT PSYCHIATRIST
IMPERIAL COLLEGE LONDON -
![Farrah Jarral]()
Dr. Farrah Jarral
WRITER, BROADCASTER & GP
-
![TADEUSZ HAWROT]()
TADEUSZ HAWROT
FOUNDER AND EXECUTIVE DIRECTOR
PSYCHEDELIC ACCESS AND RESEARCH EUROPEAN ALLIANCE -
![DR. CATHERINE SCHUSTER-BRUCE]()
DR. CATHERINE SCHUSTER-BRUCE
HEALTH REPORTER
BUSINESS INSIDER -
![George McBride]()
George McBride
CHIEF COMMERCIAL OFFICER
CLERKENWELL HEALTH -
![Matthew Wall]()
MATTHEW WALL
HEAD OF MRI APPLICATIONS
INVICRO LONDON
PARTNERS
SHORTWAVE is a pre-clinical stage biotech company focused on the development of IP-protected formulations and delivery methods of psychedelics-based medicine to treat mental illness, chronic pain and neuro degenerative diseases.
Cybin is a leading ethical biotechnology company, working with a network of world-class partners and internationally recognised scientists, on a mission to create safe and effective therapeutics for patients.
COMPASS is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first programme is researching how COMP360 psilocybin therapy could help people with treatment-resistant depression.
Negev Capital is a psychedelic medical intervention investment fund with assets of over USD$30+ million. The Company invests in drug discovery, with a focus on pre-clinical and/or Phase 1 stages of development.
Clerkenwell Health is Europe’s leading psychedelic specialty CRO offering trial design, regulatory submission, and trial delivery services. Addressing the growing unmet demand for effective mental health treatments.
FTI Consulting has built an unrivalled, global strategic communications offering to life science and healthcare companies. We design and execute communication programmes to protect and promote reputation, enhance stakeholder engagement and build a premium valuation.
Beautiful Space is Europes leading innovation in psychedelic-assisted couples therapy. Their official collaboration with Imperial College London will recruit 20 couples later this year.
Official Workshop
Official Patient Group
PsyPAN is a non-profit organisation created to connect and empower all psychedelic participants, whether they are taking part in clinical trials or receiving therapy at the various legal treatment centres being set up globally.
MEDIA PARTNERS
EVENT PARTNERSHIP
Partnering with PSYCH enables organisations to engage an audience ready to support the development of psychedelic healthcare, such as researchers, regulators and investors.
Our PURPOSE
Against the backdrop of a deepening mental health crisis, psychedelic medicines have demonstrated safety and efficacy in clinical trials.
To promote their groundbreaking potential, experts from the life sciences industry present their research at PSYCH Symposium: London.
WHY LONDON?
The UK is home to world-leading psychedelic research institutions and publicly traded companies, with direct access to London’s capital markets. This lays the foundations for a flourishing domestic industry, with the PSYCH Symposium championing the emerging ecosystem.